Yeah first time dealing with a Con Note deal, and I get your point. TBh I haven't see how ugly these get before, but in the Bluesky example below there was a tangible asset available to take.
At the moment IMU don't really have any assets (except Her-Vaxx) - they have a few unapproved drugs with licensing agreements that show promise.
So to your example below Susq. could call in their debt and swallow IMU but to what avail? Aquire a high risk speccy biotech and run it with the aid of IMU BOD?
Susq best option right now is to let IMU get back to a price that allows them to recoup their money and/or make a profit.
what's your take?
Ann: Imugene Receives A$20 million for Convertible Notes Issuance, page-341
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 26.5¢ | $500.6K | 1.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 441949 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 4132 | 2 |
View Market Depth
| Last trade - 14.29pm 07/08/2025 (20 minute delay) ? |
| IMU (ASX) Chart |